ArticleImmunology1983
Mouse immunoglobulin isotypes mediating cytotoxicity of target cells by eosinophils and neutrophils.
Article in Immunology, 1983. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 31 citations in OpenAlex.
- TM4SF1: a new vascular therapeutic target in cancer.Angiogenesis · 2014Article
- A novel adjuvant for vaccine development in the aged.Vaccine · 2010Article
- Expression of recombinant soluble Fc epsilon RI: function and tissue distribution studies.Immunology · 1995Article
- Biochemical characterization of murine Fc gamma RI.Immunology · 1993Article
- Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/epsilon BP) of the S-type lectin family: role in IgE-dependent activation.The Journal of experimental medicine · 1993Article
- The mouse Fc receptor for IgG (Ly-17): molecular cloning and specificity.Immunogenetics · 1987Article
- Role of cell surface receptors in the regulation of intracellular killing of bacteria by murine peritoneal exudate neutrophils.Infection and immunity · 1986Article
- Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures.The Journal of experimental medicine · 1985Article
- Article
- Neutrophil-mediated killing of Dipetalonema viteae microfilariae: simultaneous presence of IgE, IgG antibodies and complement is required.Immunology · 1984Article
- Polymorphonuclear leukocytes-mediated lysis of A431 cells induced by IgG1 mouse anti-epidermal growth factor receptor monoclonal antibodies.In vitro cellular & developmental biology : journal of the Tissue Culture AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The cytotoxic activity of mouse eosinophils and neutrophils in the presence of antibodies of different isotypes has been studied. Mouse monoclonal anti-hapten antibodies of all the known mouse immunoglobulin isotypes have been used to coat hapten-coupled, 51Cr-labelled target cells. Two different target cells have been used, sheep red cells, as a model for intracellular killing, and BW cell line cells, as a model for extracellular killing. It is shown that both eosinophils and neutrophils lyse sheep red cells coated with IgG1, IgG2a and IgG2b and to a lesser extent IgG3. No killing is detected when sheep red cells are coated with IgM, IgA or IgD. Neutrophils, but not eosinophils are shown to lyse IgE-coated sheep red cells. When tested against BW cells, neutrophils have been found to induce high levels of 51Cr release in the presence of IgG1, IgG2a, IgG2b and IgE, but not when IgG3, IgM, IgA or IgD were used. In contrast, no killing of BW cells by eosinophils could be detected with any of the different antibody isotypes tested. However, it is shown that eosinophils are able to kill IgG-coated BW cells when hapten coupling is increased to maximum levels or when complement is added into the system, emphasizing our previous results showing that eosinophils require much higher levels of ligands than neutrophils to be effective. To test the possibility that eosinophils have a weak IgE receptor, complement was added to IgE-coated BW cells by means of a monoclonal IgM anti-Thy-1 antibody but no cytotoxicity was detected. It cannot be completely excluded that eosinophils have IgE blocking a putative IgE receptor.
Indexed as
Identifiers
6219064PMC1454033W47500171What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.